Ethiodized Oil
PHENYTOIN/SORAFENIB [VA Drug Interaction]
Shandong Cancer Hospital and InstitutePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the PHENYTOIN/SORAFENIB [VA Drug Interaction] cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Theprubicin Shandong Cancer Hospital and Institute | Phase 2 | CCC |
Inno-206 Shandong Cancer Hospital and Institute | Phase 2 | CCC |
Same molecule, other indications
Ethiodized Oil is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →